Zydus gets regulatory nod to market Lipaglyn in Mexico
Drug firm Zydus today said it has received approval from the Mexican regulatory authority to market Lipaglyn (Saroglitazar Magnesium) used for treatment of dyslipidemia in patients with diabetes.
The company has been granted marketing approval from the Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk) to commercialise Lipaglyn in Mexico, Zydus said in a statement.
"Saroglitazar is an important scientific and medical breakthrough in our effort to develop medicines for patients suffering from hypertriglyceridemia and diabetic dyslipidemia," Zydus Group Chairman Pankaj Patel said.
PNB Gilts hits 52-week high; banks, AMCs rise too as JPMorgan announces it will include India in EM debt index
India vs Australia Free Live Streaming: When and How to Watch IND VS AUS 1st ODI Match Live on TV, Mobile Apps Online
This approval of Saroglitazar in Mexico is a major milestone for the company, he added.
"Lipaglyn is used for treatment of dyslipidemia in patients with diabetes mellitus type 2 and hypertriglyceridemia in patients with diabetes mellitus type 2 not controlled by statins," Zydus said.
Lipaglyn, a prescription drug, was first launched in India during September 2013, Zydus said.
"Over the last several years, more than 500,000 patients have been treated with Lipaglyn in India...," it added.
Shares of Cadila Healthcare, the listed entity of Zydus Group were today trading at Rs 467.50per scrip on BSE, down 2.33 per cent from its previous close.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
Retirement Planning: This small finance bank offers up to 9.5% interest rate on FDs to senior citizens, check details
SBI Retirement Benefit Fund: This SBI fund has given more than 20% return since its launch, check details
Noida Traffic Police Advisory: Roads open and close in New Delhi, Noida and Greater Noida during International Trade Show and Moto GP
PM Modi to visit Varanasi on September 23; to lay foundation of cricket stadium, inaugurate Atal Awasiya Vidyalayas